News Headlines Article

Cystic Fibrosis Drug Wins Approval of F.D.A. Advisory Panel
New York Times

A federal advisory committee on Tuesday recommended approval of a drug from Vertex Pharmaceuticals that might eventually help nearly half of patients with cystic fibrosis.

The advisory committee to the Food and Drug Administration voted 12 to 1 that the drug, which Vertex plans to call Orkambi, was safe and effective enough to be approved. The F.D.A. is supposed to decide by July 5.